Mitsikostas DD - Search Results

1

Comparing the efficacy of disease-modifying therapies in multiple sclerosis.

Mitsikostas DD, Goodin DS. Mitsikostas DD, et al. Mult Scler Relat Disord. 2017 Nov;18:109-116. doi: 10.1016/j.msard.2017.08.003. Epub 2017 Aug 18. Mult Scler Relat Disord. 2017. PMID: 29141791 Review.

2

Nocebo effects in multiple sclerosis trials: a meta-analysis.

Papadopoulos D, Mitsikostas DD. Papadopoulos D, et al. Among authors: mitsikostas dd. Mult Scler. 2010 Jul;16(7):816-28. doi: 10.1177/1352458510370793. Epub 2010 Jun 10. Mult Scler. 2010. PMID: 20538704

3

Novel candidate genes of the PARK7 interactome as mediators of apoptosis and acetylation in multiple sclerosis: An in silico analysis.

Vavougios GD, Zarogiannis SG, Krogfelt KA, Gourgoulianis K, Mitsikostas DD, Hadjigeorgiou G. Vavougios GD, et al. Among authors: mitsikostas dd. Mult Scler Relat Disord. 2018 Jan;19:8-14. doi: 10.1016/j.msard.2017.10.013. Epub 2017 Oct 24. Mult Scler Relat Disord. 2018. PMID: 29100048

4

Reply to Tsivgoulis and colleagues comments.

Goodin DS, Mitsikostas DD. Goodin DS, et al. Among authors: mitsikostas dd. Mult Scler Relat Disord. 2018 Apr;21:120-121. doi: 10.1016/j.msard.2018.03.011. Epub 2018 Mar 24. Mult Scler Relat Disord. 2018. PMID: 29724376 No abstract available.

5

Nocebo in multiple sclerosis trials: A meta-analysis on oral and newer injectable disease-modifying treatments.

Gklinos P, Papadopoulos D, Mitsikostas DD. Gklinos P, et al. Among authors: mitsikostas dd. Mult Scler Relat Disord. 2019 Nov;36:101389. doi: 10.1016/j.msard.2019.101389. Epub 2019 Sep 9. Mult Scler Relat Disord. 2019. PMID: 31525626

6

Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regression.

Papadopoulos D, Gklinos P, Psarros G, Drellia K, Delicha EM, Friede T, Mitsikostas DD, Nicholas RS. Papadopoulos D, et al. Among authors: mitsikostas dd. J Neurol. 2022 Jun;269(6):3226-3237. doi: 10.1007/s00415-021-10932-9. Epub 2022 Jan 23. J Neurol. 2022. PMID: 35066607

7

Headache disorders in multiple sclerosis: Is there an association? A systematic review and meta-analysis.

Gklinos P, Mitsikostas DD. Gklinos P, et al. Among authors: mitsikostas dd. Mult Scler Relat Disord. 2024 May;85:105536. doi: 10.1016/j.msard.2024.105536. Epub 2024 Mar 3. Mult Scler Relat Disord. 2024. PMID: 38489946 Review.

8

The existence of phonatory instability in multiple sclerosis: an acoustic and electroglottographic study.

Konstantopoulos K, Vikelis M, Seikel JA, Mitsikostas DD. Konstantopoulos K, et al. Among authors: mitsikostas dd. Neurol Sci. 2010 Jun;31(3):259-68. doi: 10.1007/s10072-009-0170-3. Epub 2009 Oct 30. Neurol Sci. 2010. PMID: 19876591

9

Nocebo as a potential confounding factor in clinical trials for Parkinson's disease treatment: a meta-analysis.

Stathis P, Smpiliris M, Konitsiotis S, Mitsikostas DD. Stathis P, et al. Among authors: mitsikostas dd. Eur J Neurol. 2013 Mar;20(3):527-533. doi: 10.1111/ene.12014. Epub 2012 Nov 12. Eur J Neurol. 2013. PMID: 23145482

10

Nocebo in clinical trials for depression: a meta-analysis.

Mitsikostas DD, Mantonakis L, Chalarakis N. Mitsikostas DD, et al. Psychiatry Res. 2014 Jan 30;215(1):82-6. doi: 10.1016/j.psychres.2013.10.019. Epub 2013 Oct 25. Psychiatry Res. 2014. PMID: 24210741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters